Keryx: This Biotech Is No Zombie

Veteran biotech investors see more than their fair share of zombies. Not the flesh-eating kind popularized on the shows like The Walking Dead, but former highflying stocks banished to obscurity after a big drug failure only to rise again without valid reason. But every once in a while, you see a company come back stronger than before it was sent into the penny-stock wilderness.

In this video, Motley Fool health-care analyst discusses how Keryx Pharmaceuticals' impressive 76% pop and how key drug Zerenex's successful trial has reinvented Keryx into more than just a zombie biotech.

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." Grab a free copy for a limited time. Just click here to access the report and find out the name of this under-the-radar company.



Read/Post Comments (1) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2220388, ~/Articles/ArticleHandler.aspx, 9/28/2016 2:51:30 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,318.05 89.75 0.49%
S&P 500 2,168.11 8.18 0.38%
NASD 5,310.24 4.53 0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 2:35 PM
KERX $5.30 Up +0.13 +2.51%
Keryx Biopharmaceu… CAPS Rating: **
AEZS $3.45 Up +0.05 +1.47%
Aeterna Zentaris CAPS Rating: *****
AFFY $0.07 Down +0.00 +0.00%
Affymax, Inc. CAPS Rating: **
AMGN $169.50 Down -2.13 -1.24%
Amgen CAPS Rating: ****
SNY $38.60 Up +0.45 +1.18%
Sanofi CAPS Rating: *****